HONG KONG, Oct 9, 2024 – (ACN Newswire) – CanSino Biologics Inc. (“CanSinoBIO” or “the Company”) has announced a milestone in its fight against polio. The company has received an additional financial boost, securing a grant exceeding US$17 million to propel its recombinant poliovirus vaccine (“VLP-Polio”) project forward…
Read More